Raymond James Financial »

Nektar Therapeutics shares owned by Raymond James Financial

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $653k 9.4k 69.81
2026-03-31 $213k 3.0k 71.95
2025-06-30 $8.1k 313 25.84

More positions owned by Raymond James Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p Mcp Etf (IJH)
Wal-Mart Stores (WMT)

View all positions for Raymond James Financial

Top funds holding Nektar Therapeutics

FMR
Two Seas Capital
BlackRock
BVF
Susquehanna International
Vanguard Capital Management
Two Sigma Investments
Vestal Point Capital
Geode Capital Management
Prosight Management
Armistice Capital
Morgan Stanley
Millennium Management
Gilder, Gagnon, Howe & Co
Citadel Advisors

View all funds holding Nektar Therapeutics